NYSE$SEM

Select Medical Holdings Corporation · Q4 2019 earnings

Q4 2019 earnings · · Investor relations

Briefing

Reported an increase in net operating revenues, income from operations, and net income compared to the same quarter prior year.

Select Medical Holdings Corporation announced its Q4 2019 results, with net operating revenues increasing by 8.7% to $1,374.6 million, income from operations increasing by 27.3% to $112.4 million, and net income increasing by 46.9% to $43.7 million compared to the same quarter of the prior year. Adjusted EBITDA increased by 16.9% to $171.9 million, and adjusted earnings per common share was $0.31 on a fully diluted basis.

  • Net operating revenues increased by 8.7% to $1,374.6 million compared to Q4 2018.
  • Income from operations increased by 27.3% to $112.4 million compared to Q4 2018.
  • Net income increased by 46.9% to $43.7 million compared to Q4 2018.
  • Adjusted earnings per common share was $0.31 on a fully diluted basis, compared to $0.20 for the same quarter, prior year.

Headline financials

Total Revenue

$1.38B

Previous: $1.27B+8.7%
EPS (adj)

$0.31

Previous: $0.20+55.0%
Net Income

$43.7M

Previous: $24.7M+77.1%
Operating Income

$112M

Previous: $88.3M+27.3%
Gross Profit

$199M

Previous: $171M+16.2%
Cash & Equivalents

$336M

Previous: $175M+91.7%
Total Assets

$7.34B

Previous: $5.96B+23.1%
Stock-Based Comp

$7.02M

Previous: $6.15M+14.1%

Revenue & EPS history

Select Medical · Revenue · Quarterly

$1.38B

Q4 2019+8.7%vs Q4 2018
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Revenue by segment

Select Medical · $910M total across 3 segments · Q4 2019

  • Critical Illness Recovery
    $455M+6.7%
  • Outpatient Rehabilitation
    $272M+7.7%
  • Rehabilitation Hospital
    $183M+20.9%

Forward guidance

Select Medical reaffirms its 2020 business outlook for net operating revenues, Adjusted EBITDA and fully diluted earnings per common share.

Tailwinds

  • Consolidated net operating revenues for the full year 2020 are expected to be in the range of $5.575 billion to $5.675 billion.
  • Adjusted EBITDA for the full year 2020 is expected to be in the range of $725.0 million to $760.0 million.
  • Fully diluted earnings per common share for the full year 2020 are expected to be in the range of $1.27 to $1.46.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2019

Historical avgQ4 2019

-0.3%

Avg return

Earnings day

+0.1%

Avg return

5 days after

+0.5%

Avg return

30 days after

49%

32 / 65 earnings

Positive

+18.8%

Q3 2018

Best reaction

-22.2%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.2%+0.1%+0.7%
Q4 2025-6.5%-7.3%+1.1%
Q3 2025-5.8%-5.1%+9.1%
Q1 2025-22.2%-17.7%-16.2%
Q4 2024-7.2%-2.9%-13.1%
Q3 2024+9.4%+13.3%+19.3%
Q2 2024-14.0%-17.2%-9.3%
Q1 2024+12.3%+17.0%+23.5%
Q4 2023+6.7%+4.6%+7.7%
Q3 2023-1.2%-2.7%+3.9%
Q2 2023-1.3%-2.5%-4.3%
Q1 2023+4.8%-0.8%-2.8%
Q4 2022-7.8%-9.1%-17.6%
Q3 2022-6.5%-10.9%+0.9%
Q2 2022-4.1%-11.1%-14.7%
Q1 2022+0.9%-4.2%+10.6%
Q4 2021+1.1%+2.2%+3.5%
Q3 2021+2.4%-0.9%-18.4%
Q2 2021-3.3%-6.9%-7.7%
Q1 2021-2.5%-3.1%+4.9%
Q4 2020+10.5%+16.9%+20.5%
Q3 2020-1.7%+8.5%+15.4%
Q2 2020+13.1%+14.7%+21.2%
Q1 2020-15.3%-12.9%-6.3%
Q4 2019+8.9%-0.1%-55.6%
Q3 2019+5.7%+10.6%+22.9%
Q2 2019-5.8%-5.8%-3.1%
Q1 2019+1.7%+3.0%-1.3%
Q4 2018+0.1%-4.8%-10.1%
Q3 2018+18.8%+21.2%+16.9%
Q2 2018-5.0%-7.5%-6.6%
Q1 2018-4.4%-3.5%-2.9%
Q4 2017+11.2%+11.4%+7.8%
Q3 2017-7.8%-9.4%-6.5%
Q2 2017+8.6%+12.7%+18.7%
Q1 2017+5.9%+1.1%+3.7%
Q4 2016+9.6%+11.6%-3.1%
Q3 2016-8.2%-6.1%-1.2%
Q2 2016+10.6%+6.3%+9.3%
Q1 2016-4.5%
Q4 2015+10.9%
Q3 2015+5.0%
Q2 2015+0.1%
Q1 2015+0.0%
Q4 2014-5.2%
Q3 2014+11.3%
Q2 2014-12.4%
Q1 2014+0.5%
Q4 2013+1.7%
Q3 2013+1.1%
Q2 2013+1.3%
Q1 2013-2.5%
Q4 2012+4.0%
Q3 2012+10.0%
Q2 2012+9.1%
Q1 2011-3.2%
Q1 2012+1.1%
Q4 2009-0.4%
Q4 2011-0.4%
Q3 2010-2.4%
Q3 2011-2.4%
Q4 2010-15.8%
Q2 2010-15.8%
Q2 2011-15.8%
Q1 2010-7.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro